Viracta Therapeutics, Inc. (VIRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0188
+0.0009 (5.03%)
May 28, 2025, 11:10 AM EDT
Viracta Therapeutics Market Cap
Viracta Therapeutics has a market cap or net worth of $711.42 thousand as of May 30, 2025. Its market cap has decreased by -97.65% in one year.
Market Cap
711.42K
Enterprise Value
-3.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since February 25, 2021, Viracta Therapeutics's market cap has decreased from 8.68M to 711.42K, a decrease of -91.81%. That is a compound annual growth rate of -44.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 29, 2025 | 711.42K | -88.88% |
Dec 31, 2024 | 6.39M | -70.95% |
Dec 29, 2023 | 22.02M | -60.52% |
Dec 30, 2022 | 55.77M | -59.05% |
Dec 31, 2021 | 136.19M | 1,468.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.65B |
Veradigm | 721.76M |
Nika Pharmaceuticals | 672.83M |
Tian'an Technology Group | 591.73M |
Elite Pharmaceuticals | 568.48M |
Glass House Brands | 452.21M |
CytoDyn | 423.89M |
Northwest Biotherapeutics | 388.88M |